Literature DB >> 16181175

Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia.

Takuya Watanabe1, Akira Miyazaki, Takashi Katagiri, Hideki Yamamoto, Tsunenori Idei, Takashi Iguchi.   

Abstract

OBJECTIVES: To determine whether decreased serum insulin-like growth factor-1 (IGF-1) levels could be a risk factor for dementia in older people.
DESIGN: Case control study.
SETTING: Showa University Karasuyama Hospital, Tokyo, Japan. PARTICIPANTS: A total of 436 Japanese elderly subjects: 106 patients with Alzheimer's disease (AD), 103 patients with vascular dementia (VaD), and 227 age-matched controls without dementia. MEASUREMENTS: Serum concentrations of IGF-1 and atherogenic lipoproteins, carotid artery intima-media thickness (IMT), and plaques were determined.
RESULTS: Mini-Mental State Examination (MMSE) scores were positively correlated with serum IGF-1 concentrations as well as mean blood pressure or body mass index and were negatively correlated with age, serum low-density lipoprotein cholesterol and lipoprotein(a) concentrations, and carotid IMT. Serum IGF-1 concentrations had a significant inverse correlation with carotid IMT. Analysis across the IGF-1 quartiles revealed a threshold effect of low IGF-1 on MMSE score in subjects with the IGF-1 levels of 140 ng/mL or less (50% percentile) versus those with IGF-1 levels greater than 140 ng/mL. Multiple logistic regression concerning AD and VaD retained serum IGF-1 concentrations of 140 ng/mL or less and carotid IMT of 0.9 mm or more. Patients with AD and VaD had significantly lower IGF-1 concentrations and greater mean IMT than nondemented controls.
CONCLUSION: These results suggest that decreased serum IGF-1 level and the progression of carotid atherosclerosis could play a role as independent risk factors for dementia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16181175     DOI: 10.1111/j.1532-5415.2005.53524.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  35 in total

Review 1.  The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.

Authors:  Jesse Costales; Alexander Kolevzon
Journal:  Neurosci Biobehav Rev       Date:  2016-01-15       Impact factor: 8.989

2.  Selective breeding for endurance running capacity affects cognitive but not motor learning in rats.

Authors:  Jan Wikgren; Georgios G Mertikas; Pekka Raussi; Riina Tirkkonen; Laura Äyräväinen; Markku Pelto-Huikko; Lauren G Koch; Steven L Britton; Heikki Kainulainen
Journal:  Physiol Behav       Date:  2012-01-20

Review 3.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

4.  Association between Insulin-Like Growth Factor-1 and Frailty among Older Adults.

Authors:  T Doi; H Makizako; K Tsutsumimoto; R Hotta; S Nakakubo; K Makino; T Suzuki; H Shimada
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

5.  Circulating insulin-like growth factor 1 and insulin-like growth factor binding protein-3 level in Alzheimer's disease: a meta-analysis.

Authors:  Xiaohui Hu; Yan Yang; Daokai Gong
Journal:  Neurol Sci       Date:  2016-07-05       Impact factor: 3.307

6.  Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels.

Authors:  Marta Bolós; Silvia Fernandez; Ignacio Torres-Aleman
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

7.  Insulin and IGF-I prevent brain atrophy and DNA loss in diabetes.

Authors:  Predrag Serbedzija; James E Madl; Douglas N Ishii
Journal:  Brain Res       Date:  2009-09-23       Impact factor: 3.252

8.  Thyroid hormones are associated with poorer cognition in mild cognitive impairment.

Authors:  Patrick Quinlan; Arto Nordlund; Karin Lind; Deborah Gustafson; Ake Edman; Anders Wallin
Journal:  Dement Geriatr Cogn Disord       Date:  2010-08-26       Impact factor: 2.959

9.  The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.

Authors:  Kendra L Puig; Joshua A Kulas; Whitney Franklin; Sharlene G Rakoczy; Giulio Taglialatela; Holly M Brown-Borg; Colin K Combs
Journal:  Neurobiol Aging       Date:  2016-01-06       Impact factor: 4.673

10.  Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.

Authors:  Eric R Braverman; Thomas J H Chen; Thomas J Prihoda; William Sonntag; Brian Meshkin; B William Downs; Julie F Mengucci; Seth H Blum; Alison Notaro; Vanessa Arcuri; Michael Varshavskiy; Kenneth Blum
Journal:  Age (Dordr)       Date:  2007-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.